← Leaderboards
William R. Freeman
University Of California San Diego
$11,346,515
Attributed
$12,886,031
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,886,031 · 5
By mechanism
R01$12,070,624 · 4
P30$815,407 · 1
Top collaborators
- Dirk-Uwe G Bartsch5 shared
- Truong Q Nguyen5 shared
- Cheolhong An4 shared
- Michael J Sailor3 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Jeffrey W Holmes$11,105,035
- Howard A Rockman$36,912,571
- H. Kirk Hammond$20,059,661
- Joan Heller Brown$27,246,985
- Sotirios Tsimikas$7,692,120
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaRetinal DiseasesDrug Delivery SystemsTissuesAreaEvaluationAntiviral AgentsBlindnessPharmaceutical PreparationsBaseEye DiseasesImageLipidsWaterStructureCellsVisionRetinalGrantCytomegalovirus RetinitisAffectFundingResearch PersonnelClinical Trials
Grant awards (33)
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization$413,374
R01 · FY2025 · EY · contact PI
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization$413,374
R01 · FY2024 · EY · contact PI
SCH: Multimodal Retina Image Alignment and Applications$273,134
R01 · FY2024 · EY · contact PI
SCH: Multimodal Retina Image Alignment and Applications$92,970
R01 · FY2024 · EY
Intracellular RNA Nanoparticle Therapeutics to Treat Retinal Neovascularization$423,374
R01 · FY2023 · EY · contact PI
SCH: Multimodal Retina Image Alignment and Applications$282,482
R01 · FY2023 · EY
SCH: Multimodal Retina Image Alignment and Applications$282,085
R01 · FY2022 · EY
SCH: Multimodal Retina Image Alignment and Applications$298,932
R01 · FY2021 · EY
Tissue Processing and Confocal Microscopy$170,343
P30 · FY2016 · EY · contact PI
Tissue Processing and Confocal Microscopy$11,634
P30 · FY2016 · EY · contact PI
Tissue Processing and Confocal Microscopy$170,412
P30 · FY2015 · EY · contact PI
Tissue Processing and Confocal Microscopy$172,735
P30 · FY2014 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$638,882
R01 · FY2013 · EY · contact PI
Tissue Processing and Confocal Microscopy$132,783
P30 · FY2013 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$672,507
R01 · FY2012 · EY · contact PI
Tissue Processing and Confocal Microscopy$157,500
P30 · FY2012 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$684,843
R01 · FY2011 · EY · contact PI
Crystalline Antiproliferative Drugs for Intraocular Diseases$500,670
R01 · FY2011 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$718,073
R01 · FY2010 · EY · contact PI
Crystalline Antiproliferative Drugs for Intraocular Diseases$510,230
R01 · FY2010 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$594,502
R01 · FY2009 · EY · contact PI
Crystalline Antiproliferative Drugs for Intraocular Diseases$463,183
R01 · FY2009 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$14,724
R01 · FY2009 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$569,322
R01 · FY2008 · EY · contact PI
Crystalline Antiproliferative Drugs for Intraocular Diseases$480,235
R01 · FY2008 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$570,850
R01 · FY2007 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$602,034
R01 · FY2006 · EY · contact PI
Studies of Retinopathy of AIDS in the HAART Era$554,720
R01 · FY2005 · EY
Studies of Retinopathy of AIDS in the HAART Era$470,010
R01 · FY2004 · EY
Studies of Retinopathy of AIDS in the HAART Era$413,829
R01 · FY2003 · EY
Studies of Retinopathy of AIDS in the HAART Era$402,197
R01 · FY2002 · EY
Studies of Retinopathy of AIDS in the HAART Era$385,913
R01 · FY2001 · EY
STUDY AND TREATMENT OF RETINOPATHY ASSOCIATED WITH AIDS$344,175
R01 · FY2000 · EY